Results 11 to 20 of about 35,326 (236)

Prevalence and determinants of active trachoma among preschool-aged children in Dembia District, Northwest Ethiopia [PDF]

open access: goldInfectious Diseases of Poverty, 2017
Background Trachoma is an infectious eye disease caused by Chlamydia trachomatis, which is the leading infectious cause of blindness worldwide. In areas where trachoma is endemic, active trachoma is common among preschool-aged children, with varying ...
Ayanaw Tsega Ferede   +3 more
doaj   +2 more sources

Active Trachoma Cases in the Solomon Islands Have Varied Polymicrobial Community Structures but Do Not Associate with Individual Non-Chlamydial Pathogens of the Eye [PDF]

open access: yesFrontiers in Medicine, 2018
BackgroundSeveral non-chlamydial microbial pathogens are associated with clinical signs of active trachoma in trachoma-endemic communities with a low prevalence of ocular Chlamydia trachomatis (Ct) infection.
Robert M. R. Butcher   +12 more
doaj   +5 more sources

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages [PDF]

open access: yesNature Communications, 2016
Chlamydia trachomatis isolates causing a blinding disease (trachoma) form a single lineage that is different from the lineages causing urogenital infections. Here, Andersson et al.
Patiyan Andersson   +14 more
doaj   +2 more sources

Cost-effectiveness of adding measurement of Chlamydia trachomatis infection and serology to trachoma prevalence surveys in Tanzania and Mozambique. [PDF]

open access: yesPLoS Neglected Tropical Diseases
BackgroundAccurate methods to measure trachoma prevalence are critical to monitor progress and guide mass drug administration as countries near elimination.
Emily C Decker   +14 more
doaj   +2 more sources

Global, Regional, and National Burden of Trachoma: Cross-Country Inequalities, 1990–2021, with Projections to 2040 [PDF]

open access: yesOphthalmology and Therapy
Introduction In this work, we aim to evaluate the trends and cross-country inequalities of the global trachoma burden from 1990 to 2021 and to project its burden to 2040. Methods This study was a systematic analysis of the Global Burden of Diseases Study
Yang Meng   +4 more
doaj   +2 more sources

Hidden in Plain Sight: The Enduring Challenge of Neglected Tropical Diseases in Khartoum State, Sudan. [PDF]

open access: yesJ Trop Med
Background Neglected tropical diseases (NTDs) disproportionately affect impoverished populations in tropical regions. Despite their significant health burden, data on NTD prevalence and distribution are limited in many areas, including Khartoum State, Sudan.
Rahamtalla BM.
europepmc   +2 more sources

Prevalence and Genetic Characterization of <i>Chlamydia trachomatis</i> Isolates From Reproductive Age Women in Trachoma-Endemic and Nonendemic Areas of Tanzania. [PDF]

open access: yesCan J Infect Dis Med Microbiol
Background Chlamydia trachomatis is the leading cause of sexually transmitted infections globally, responsible for various conditions including trachoma, genital infections, lymphogranuloma venereum, reactive arthritis, pneumonia, and neonatal conjunctivitis. This bacterium has 19 identified genotypes.
Senkoro RH   +3 more
europepmc   +2 more sources

Surgical output within the Fast Track Initiative against trachoma in Amhara region, Ethiopia

open access: yesJournal of Infection in Developing Countries, 2022
Introduction: Trachomatous trichiasis (TT) is the advanced stage of trachoma where lashes touch the globe of the eye causing permanent damage. Without eyelid surgery, TT can lead to irreversible blindness.
Begashaw Hailemariam   +12 more
doaj   +1 more source

Optimizing cluster survey designs for estimating trachomatous inflammation–follicular within trachoma control programs

open access: yesInternational Journal of Infectious Diseases, 2022
: Objectives: The World Health Organization recommends mass drug administration (MDA) with azithromycin to eliminate trachoma as a public health problem. MDA decisions are based on prevalence estimates from two-stage cluster surveys.
Julia W. Gallini   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy